As Lead Counsel, Liisa Nogelo, J.D., leads the legal team supporting the Bill & Melinda Gates Medical Research Institute. In this role, she develops and executes legal and IP strategies, manages risk, advises the board and leadership team, leads complex transactions, and provides strategic and operational support to achieve the…
Current Opportunities If you share our belief that all lives have equal value, and that science and technology can change lives for the better, we would love to connect with you. Please review our Current Opportunities through the link below and apply directly for consideration. More information can be found on…
September 1, 2022•Publication
November 5, 2021•Publication
Gates MRI’s Head of Bioassay Development and Operations, Joleen T. White, published research that provides a hypothetical case study to present an immunogenicity risk assessment for a multi-specific therapeutic as part of an Investigational New Drug (IND) application.
Development of treatments that may help lower the rates of newborn and child mortality
Gates MRI focuses on programs aimed at reducing the burden of tuberculosis (TB), malaria, diarrheal diseases, and maternal, newborn, and child illnesses in low-and-middle-income countries (LMICs). LMICs, a term originally defined by the World Bank 1, are often the most impacted by such diseases. The institute works through collaborating…
February 14, 2024•Publication
March 16, 2022•News Article
Gates MRI’s Clinical Development Leader, Alemnew Dagnew, gave an interview about the latest tuberculosis vaccine study at Gates MRI and the future of tuberculosis worldwide.
Caused by a number of pathogens and a major cause of mortality in LMICs
Who we are The Bill & Melinda Gates Medical Research Institute is a non-profit organization dedicated to the development and effective use of novel biomedical interventions addressing substantial global health concerns, for which investment incentives are limited. The institute works through collaborating partners and organizations, coordinating and driving the full…
November 16, 2023•Publication